LYSOGENE
Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders . Their mission is to radically improve the health of patients suffering from incurable life threatening conditions. They do this by developing AAV vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system.
LYSOGENE
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Neuilly-sur-seine, Ile-de-France, France
Country:
France
Website Url:
http://www.lysogene.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 56 88 52 86
Total Funding:
30.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
AMR Centre
AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Calypso Biotech
Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.
Clene Nanomedicine
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
ETHRIS
ETHRIS is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.
FinVector
FinVector is a world leader in the research and development of Viral-Based Gene Therapy products.
IAG, Image Analysis Group
IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
POLYNEURON
Polyneuron is a pharmaceutical company, committed to the development of a new drug class for the treatment of autoimmune disorders.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Employees Featured
Founder
Stock Details
Investors List
European Investment Bank
European Investment Bank investment in Post-IPO Debt - LYSOGENE
Bpifrance
Bpifrance investment in Post-IPO Debt - LYSOGENE
Novo Holdings
Novo Holdings investment in Series A - LYSOGENE
Sofinnova Investments
Sofinnova Investments investment in Series A - LYSOGENE
Official Site Inspections
http://www.lysogene.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.56 K
- Host name: cluster013.ovh.net
- IP address: 213.186.33.24
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
